Annexon Bioscience's Seed VC Round

Annexon Bioscience raised a round of funding on August 22, 2011. Investors include F-Prime Capital.

Annexon Bioscience is developing therapeutics for neurodegenerative and autoimmune disorders. Specifically, the company is working to develop a pipeline of classical complement pathway inhibitors that…

Articles about Annexon Bioscience's Seed VC Round: